Clinical Roundup Elahere shows survival benefit in long-term analysis for ovarian cancer patients in phase III study March 21, 2025Vol.51 No.11
Clinical Roundup Genmab’s Rina-S shows promise in treating advanced ovarian cancer March 21, 2025Vol.51 No.11
Clinical Roundup KRAS mutation is a significant predictor of metastasis and survival in pancreatic cancer, study shows March 21, 2025Vol.51 No.11
Clinical Roundup A post-treatment blood test could inform future cancer therapy decisions, study shows March 21, 2025Vol.51 No.11
Clinical Roundup Immunovia completes second clinical validation of next-gen pancreatic cancer test March 21, 2025Vol.51 No.11
Clinical Roundup Classifying childhood brain cancers by immune response may improve diagnostics and treatments March 21, 2025Vol.51 No.11
Drugs & Targets FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1) March 21, 2025Vol.51 No.11
Drugs & Targets EC expands approval for Breyanzi for r/r follicular lymphoma March 21, 2025Vol.51 No.11
Regulatory News Backlog of work grows at NIH as staff members are being hounded to quit March 14, 2025Vol.51 No.10By Paul Goldberg, Jacquelyn Cobb and Claire Marie Porter
Guest Editorial Rathmell: My mentor recognized a cliff I was going to fall off before I did.“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.” March 14, 2025Vol.51 No.10By W. Kimryn Rathmell
